16:45 EDT 60 Degrees Pharmaceuticals Inc trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SXTP:
- 60 Degrees Pharmaceuticals Suspends Phase IIB Study of Tafenoquine for COVID-19, Pivots to Refocus on Commercialization of Treatments for Malaria and Tick-Borne Diseases
- 60 Degrees Pharmaceuticals initiated with a Buy at Ascendiant
- 60 Degrees Pharmaceuticals withdraws ACLR8-LR IND application
- 60 Degrees Pharma Withdraws COVID Phase IIB IND, Will Resubmit Pending Assessment of Ability to Meet FDA Requirements
- 60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference